Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software solutions, has joined forces with the Montpellier Cancer Institute (ICM) through a partnership aimed at validating and then deploying its new platform dedicated to oncology in real-life situations, with the objective of using it in clinical routine.

Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software solutions ("Intrasense" or the "Company") announces that the Guerbet Group (FR0000032526 - GBT) has acquired a 39% stake in its share capital through a reserved share capital increase for a total amount of 8.8 million euros at an issuance price of 0.44 euro per share, representing a premium of 34.15% over the last closing price of the shares of Intrasense (the "Capital Increase").

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian® (the "Group"), today announces its 2022 IFRS Group consolidated half-year financial results.

Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software solutions, and MV, a key global player in the development of healthcare management software, announced the signing of a new contract to deploy the innovative solutions of the Myrian platform in Brazil, Panama, Colombia and Argentina.

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian^®, is pleased to announce its participation in the Journées Francophones de Radiologie (JFR). The exhibition will be held at the Palais des Congrès in Paris. The 2022 edition is dedicated to the continuity of care pathways and to "digital health". This international medical imaging congress will gather more than 10,000 visitors between October 7 and 10